Association of increased progression-free survival in primary glioblastomas with lymphopenia at baseline and activation of NK and NKT cells after dendritic cell immunotherapy.
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-31 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2087)Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.
/in Dendritic Cells, International Publications /von 2014-05-31 / J Clin Oncol 32:5s, 2014 (suppl; abstr 7583)A feasibility and safety study of vaccination with poly-ICLC and peptide-pulsed dendritic cells in patients with metastatic, locally advanced unresectable, or recurrent pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-05-30 / J Clin Oncol 32, 2014 (suppl; abstr e15254)Dendritic cell immunotherapy for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-21 / Expert Rev Anticancer Ther 2014 Jul;14(7):761-3Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective
/in Dendritic Cells, International Publications /von 2014-05-16 / Expert Opin Biol Ther 2014 Sep;14(9):1259-70Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2014-05-13 / Cytotherapy 2014 Jul;16(7):946-64Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-13 / J Immunother Cancer 2014;2:10The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-05-07 / J Ovarian Res 2014 May;7:48Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer, Uterine Cancer /von 2014-05-02 / Expert Rev Clin Immunol 2014 Jun;10(6):705-11IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de